Constipation outcomes in children with and without autism spectrum disorder: Insights from a tertiary motility

Umair Khalid1, Rishi Bolia1,2, Joshua Bunt3

  • 1Department of Gastroenterology, Hepatology and Liver Transplant, Queensland Children's Hospital, Brisbane, Queensland, Australia.

Insights

Children with autism spectrum disorder (ASD) have worse constipation outcomes and lower treatment adherence than peers without ASD. Autism severity did not significantly impact constipation prognosis in this study.

Area of Science:

  • Pediatric Gastroenterology
  • Neurodevelopmental Disorders
  • Clinical Outcomes Research

Background:

  • Autism spectrum disorder (ASD) frequently co-occurs with chronic constipation, posing a significant clinical challenge.
  • Limited comparative data exists on constipation management and outcomes in children with and without ASD, or across ASD severity levels.

Purpose of the Study:

  • To compare constipation outcomes at 1-year and last follow-up between children with and without ASD.
  • To evaluate the influence of ASD severity on constipation prognosis.

Main Methods:

  • Retrospective analysis of 196 children with chronic constipation managed in a tertiary motility service.
  • Extracted data included demographics, comorbidities, adherence, interventions, and outcomes.
  • Subgroup analyses assessed outcomes across ASD severity levels; statistical comparisons used Chi-square, Mann-Whitney U, and Kruskal-Wallis tests (p < 0.05).

Main Results:

  • The ASD cohort (n=74) showed higher male prevalence, lower medication adherence (56.8% vs. 76.2%), and poorer constipation resolution (11% vs. 25%) compared to the non-ASD group (n=122).
  • Attention deficit hyperactivity disorder (ADHD) was significantly more prevalent in the ASD group (50% vs. 13.9%).
  • Constipation outcomes and compliance were generally similar across ASD severity levels, with lowest toileting compliance noted in Level 3.

Conclusions:

  • Children with ASD experience poorer constipation resolution and lower treatment adherence compared to non-ASD children.
  • ASD severity did not significantly alter constipation outcomes, suggesting a need for tailored interventions.
  • Multidisciplinary strategies are essential to improve adherence and optimize outcomes for children with ASD and chronic constipation.
Abstract

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.